Under-eye exosome consultation in Business Bay
Under-eye exosome treatment in Dubai, carefully assessed
An under-eye exosome consultation should identify the exact product, source, intended use, delivery method, eye-area concern, evidence, and alternatives before treatment is considered. The delicate eye area requires its own assessment pathway.
- Business BayDubai clinic
- Consultation-led carePersonal planning and clear next steps
Ask what the product is, how it is used, and why it is being considered
Product identity, source, method, eye-area concern, evidence, regulatory context, and alternatives are all part of a responsible under-eye exosome discussion.
Swipe through the decision pointsExact product
The clinician identifies the exact product and does not rely on a generic “exosome” label.
Delivery method
Injection and Dermapen microneedling are different methods. Eye-area suitability, product information, risks and evidence must be reviewed separately.
The eye-area concern
Skin quality should be distinguished from hollowing, colour change, puffiness, and other eye-area pathways.
Evidence and alternatives
The clinician explains known limits and whether another treatment is more appropriate for the concern.
At a glance
Under-eye exosome treatment needs a product-specific safety and evidence conversation
Exosome is not one standard treatment. The consultation identifies the exact product, source, proposed method, intended use, delicate treatment area, evidence, limitations, and whether another route is more appropriate.
Your consultation identifies what is being considered, why, how it is proposed to be used, and what the realistic alternatives are.
Exact product required
The product identity, source, and proposed use are clarified before treatment is discussed.
Method matters
Different delivery methods have different suitability, aftercare, and evidence considerations.
Delicate-area assessment
Under-eye concerns are not treated as a generic facial treatment decision.
Evidence is discussed openly
The consultation covers uncertainty, limitations, and alternatives before you decide.
Aftercare is individual
You receive guidance appropriate to the exact product and treatment approach agreed.
Mahan currently uses QUARTIZ exosome, with injection or Dermapen microneedling considered after skin assessment. This does not establish that either method is suitable for the delicate under-eye area; the doctor must assess the exact proposed use separately.
Choosing the right approach
When an under-eye exosome discussion may fit—and when it should not proceed
Suitability requires an exact-product, method, eye-area condition, evidence, treatment-history, and medical-context review. A broad treatment name is not enough.
Often discussed for
- People seeking a cautious, product-specific discussion of an under-eye exosome option.
- Patients willing to review product information, method, limitations, and alternatives before deciding.
- People with a defined eye-area skin concern rather than a request for a universal regenerative result.
May need another approach
- A request to use an unspecified product or a method that cannot be clearly described.
- A hollowing, pigmentation, vascular, puffiness, or health concern that needs another assessment pathway.
- Anyone seeking certainty, a guaranteed outcome, or a product chosen from a social-media trend alone.
Need a tailored answer?
Start by asking exactly what is being considered
Tell us your eye-area concern and any product or method you have seen. The consultation can clarify the product, evidence, alternatives, and whether treatment is appropriate.
Your consultation journey
From product identification to a clear under-eye decision
A responsible exosome discussion makes the product, method, limits, and aftercare clear before any treatment is considered.
- 01
Review the concern and history
We discuss the eye-area concern, relevant health information, recent procedures, and what you want to understand.
- 02
Identify the product and method
The clinician explains the exact product and proposed method, including whether another treatment is more appropriate.
- 03
Agree next steps or an alternative
If treatment is suitable, you receive individual guidance. If it is not, the clinician explains the safer or clearer next route.
Suitability & safety
Product transparency and suitability come before an under-eye exosome discussion
Share relevant health information, allergies, pregnancy or breastfeeding status, current skin concerns, eye-related symptoms, medicines, and recent procedures before treatment is considered.
- The exact product, source, intended use, and method must be identified before a treatment plan is agreed.
- The clinician may recommend an alternative, delay treatment, or decline treatment where the product, method, evidence, or medical context is not appropriate.
- Possible effects, uncertainty, aftercare, and when to contact the clinic are explained before you decide.
- The FDA states that there are no FDA-approved exosome products and has reported serious adverse events involving unapproved products marketed as containing exosomes. This is US context, not a determination of QUARTIZ’s UAE status or a report about Mahan.
Urgent: Seek immediate medical attention for difficulty breathing or swallowing, any vision change, sudden weakness or difficulty speaking, severe or increasing pain, or white, grey, blue or mottled skin after treatment. Do not wait for a routine clinic reply. Seek prompt medical advice for worsening swelling, spreading redness, fever or unusual discharge.
This page provides general information and does not replace an individual medical consultation.
Suitability, product choice, treatment areas, and limitations are discussed before you decide.
02Individual treatment planThe suitable treatment, product, and placement are selected only after an individual clinical assessment.
03Written aftercareYou receive individual aftercare guidance and clear advice about when to contact the clinic.
Care at Mahan
A cautious under-eye exosome discussion with product transparency
Owner-verified clinic team. The clinic team starts with your skin, health context, treatment history, and expectations before discussing an appropriate plan.
Meet the Mahan clinic
Co-Founder
Co-Founder and General Manager
Questions, answered
Under-eye exosome treatment FAQs
Useful general information first; a clinician can then make it specific to you and the treatment route being discussed.
Are all under-eye exosome treatments the same?
No. Products and methods differ. The clinician should identify the exact product, source, proposed use, and method before treatment is considered.
Can it treat every dark-circle concern?
No. The clinician first distinguishes skin quality from hollowing, pigmentation, vascular visibility, puffiness, and other eye-area concerns.
Can an exosome option be combined with another procedure?
Any combination depends on the exact product, delivery method, eye-area condition, recent procedures, and clinical assessment.
How long does the visit take?
Appointment timing depends on the exact method and agreed plan. The clinic explains timing after the product and method are clear.
How do I arrange a consultation?
Use the form, call the clinic, or message us on WhatsApp.
Clinical information sources
Evidence behind this under-eye exosome treatment guide
General treatment information was checked against clinical, regulatory, product, or evidence-review material. Your clinician confirms what applies to your individual plan.
Speak with the clinic
Start with an under-eye exosome treatment consultation
Tell us what you would like to discuss and any previous skin or injectable treatment. An enquiry begins planning and does not confirm treatment.
Message us on WhatsApp